Is There Potential for Repurposing Statins as Novel Antimicrobials? | Zendy

Emma Hennessy | Zendy; Claire Adams | Zendy; F. Jerry Reen | Zendy; Fergal O’Gara | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Is There Potential for Repurposing Statins as Novel Antimicrobials?

Author(s) -

Emma Hennessy,

Claire Adams,

F. Jerry Reen,

Fergal O’Gara

Publication year - 2016

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.00192-16

Subject(s) - repurposing , antimicrobial , in vivo , medicine , statin , anti infective agents , pharmacology , drug repositioning , drug , biology , microbiology and biotechnology , ecology

Statins are members of a class of pharmaceutical widely used to reduce high levels of serum cholesterol. In addition, statins have so-called "pleiotropic effects," which include inflammation reduction, immunomodulation, and antimicrobial effects. An increasing number of studies are emerging which detail the attenuation of bacterial growth and in vitro and in vivo virulence by statin treatment. In this review, we describe the current information available concerning the effects of statins on bacterial infections and provide insight regarding the potential use of these compounds as antimicrobial therapeutic agents.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research